insurance semaglutide 💉 Medicare is making popular weight-loss medications more affordable for some patients. Starting July 1, 2026, eligible Medicare beneficiaries may be able to access certain GLP-1 weight-loss drugs for just $50 per A pilot program will cover

Once again, we will only submit prior authorization for medical indications as determined by the FDA

Precision health benefits Evidence suggests that microdosing could unlock longevity benefits like improved immunity, heart health, and cognitive function

The data showed a statistically significant association between a lower risk of Alzheimers and the use of GLP-1RAs and SGLT2is compared with other glucose-lowering medications

Our B12 injections provide a direct route to increase B12 levels, bypassing the gastrointestinal tract and helping to alleviate symptoms such as fatigue and neurological issues

Stay connected with your healthcare provider for ongoing support

This is the single most common qualifying condition